Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

EPIRUS Biopharmaceuticals Inc


Ticker Change

Company Profile for EPIRUS Biopharmaceuticals Inc (ZLCS)

EPIRUS Biopharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company's drug pipeline includes an arthritis formula in phase 2 development.

Contact Information

EPIRUS Biopharmaceuticals Inc

699 Boylston Street
11th Floor
Cambridge, MA 02116
United States
Phone: 1-617-301-7000
Fax: 1-617-301-7010

Key Executives for EPIRUS Biopharmaceuticals Inc (ZLCS)

Amit D MunshiPresident/CEOThomas A SheaChief Financial Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil